- How many Verio meters are in use today? Worldwi
Post# of 11802
(Total Views: 276)
Posted On: 02/04/2018 12:35:59 PM
Re: weaver_525 #4008
- How many Verio meters are in use today? Worldwide, about 2.5 million, but less popular in the U.S. where the Verio and Verio Flex meters are used.
- I read that the Verio meets the ISO Standard 2013. It also meets the ISO 2015 standard, and would most likely meet the FDA 2014 Guidance standard. Except for a stricter HCT range and criteria, all of the standards are +/- 15%.
- could there be difficulties for an alternative product with the stricter regulations that are in place? Why? Do you buy into the argument that alternative strips are somehow lesser strips?
- How long would it take until the rubber hits the road? Of course, it's all about money. Money to do a once in a product life cycle crash development. And I know the moment I said this about money, the inner trader in you would come out and you would think its a bad idea, like you think GenChoice and GenPrecis are bad ideas. I get that. However, product developments are not usually based on the opinions of stock traders.
- What do you think would be the implications for the negotiations between J&J and Sinocare? Money. J&J probably feels that it has milked these markets for as long as and as hard as they can. Now its time, or even past time, to exit.
- One more question concerning GenSure!: are there legal actions expected concerning the launch of this product? I don't expect any. But perhaps with a little help from people masquerading as DECN shareholders, they could convince J&J to sue, where the suit would be filed primarily to foment more negativity by DECN shareholders surrounding DECN.
J&J's OneTouch Select is an almost identical copy of OneTouch Ultra. J&J said so in their 510K filing. Their clinical trials were run on only 100 patients in what is called an Accuracy Study. DECN owns a patent license to the OneTouch Ultra patents, two of which are expired and one of which was killed. But, people masquerading as DECN shareholders have libeled Mr. Berman into oblivion in public forums. J&J reads these message boards and speaks to the authors of the posts. It might just be worth $350K to bring a suit. A suit would be met with glee over on iHub. What do you think?
- I read that the Verio meets the ISO Standard 2013. It also meets the ISO 2015 standard, and would most likely meet the FDA 2014 Guidance standard. Except for a stricter HCT range and criteria, all of the standards are +/- 15%.
- could there be difficulties for an alternative product with the stricter regulations that are in place? Why? Do you buy into the argument that alternative strips are somehow lesser strips?
- How long would it take until the rubber hits the road? Of course, it's all about money. Money to do a once in a product life cycle crash development. And I know the moment I said this about money, the inner trader in you would come out and you would think its a bad idea, like you think GenChoice and GenPrecis are bad ideas. I get that. However, product developments are not usually based on the opinions of stock traders.
- What do you think would be the implications for the negotiations between J&J and Sinocare? Money. J&J probably feels that it has milked these markets for as long as and as hard as they can. Now its time, or even past time, to exit.
- One more question concerning GenSure!: are there legal actions expected concerning the launch of this product? I don't expect any. But perhaps with a little help from people masquerading as DECN shareholders, they could convince J&J to sue, where the suit would be filed primarily to foment more negativity by DECN shareholders surrounding DECN.
J&J's OneTouch Select is an almost identical copy of OneTouch Ultra. J&J said so in their 510K filing. Their clinical trials were run on only 100 patients in what is called an Accuracy Study. DECN owns a patent license to the OneTouch Ultra patents, two of which are expired and one of which was killed. But, people masquerading as DECN shareholders have libeled Mr. Berman into oblivion in public forums. J&J reads these message boards and speaks to the authors of the posts. It might just be worth $350K to bring a suit. A suit would be met with glee over on iHub. What do you think?
(3)
(0)Decision Diagnostics Corp (DECN) Stock Research Links
Scroll down for more posts ▼